Bharat Biotech says typhoid vaccine shown to be safe, effective in human trialsPost published:October 2, 2017Post category:Industry NewsClinical studies showed 87% effectiveness for Typbar-TCV typhoid vaccine, says Bharat Biotech Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMeet the Man Who Designed Your iPhone (It Wasn’t All Steve Jobs) Next PostD-Mart’s rising brand value shows that hyperlocal pays You Might Also Like IOC, ONGC, 9 other oil PSUs on track to match $16 billion spending May 19, 2017 Balluff releases BMP magnetic position sensors April 29, 2019 IoT key to better social, digital infrastructure, say analysts March 10, 2017